meglumine antimoniate has been researched along with Multiple Organ Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortes, C; Cuestas, D; Forero, Y; Galvis, I; Mora, S; Motta, A; Peñaranda, E; Pérez, C; Puentes, J; Velasquez, O | 1 |
Blanquer, J; Llombart, A; Mesejo, A; Núñez, C; Pérez, PL; Ruiz, F; Simó, M | 1 |
1 review(s) available for meglumine antimoniate and Multiple Organ Failure
Article | Year |
---|---|
Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): one more reason for a new effective treatment against leishmaniasis.
Topics: Antiprotozoal Agents; Drug Hypersensitivity Syndrome; Humans; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Multiple Organ Failure | 2018 |
1 other study(ies) available for meglumine antimoniate and Multiple Organ Failure
Article | Year |
---|---|
[Visceral leishmaniasis and multiple organ failure].
Topics: Adolescent; Animals; Bone Marrow; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Multiple Organ Failure; Organometallic Compounds | 1993 |